• About PRIME
  • Advertise With Us
  • Contact Us
Advertisement
PRIME Journal
  • Home
  • Digital Issue
  • Categories
    • Energy Based Devices
    • Minimally Invasive
    • Skincare
    • Injectables
    • Dermatology
    • Anti-ageing
    • Body Contouring
    • Invasive treatments
  • Features
    • Case Study
    • PRIME People
    • Company Profile
    • Industry Analysis
    • Sponsored Features
  • News
  • Sign Up
  • Login

Select Page

Advertisement

PRIME July/August 2023

Digital Magazine, News

Share:

PreviousA non-invasive approach for jawline contouring
NextPRIME September/October 2023 issue

Related Posts

Groundbreaking Discoveries for Treatment of Back of Head Razor Bumps

Groundbreaking Discoveries for Treatment of Back of Head Razor Bumps

August 4, 2019

RealSelf Launches Fellowship to Support Medical Volunteers and Raise Awareness of Need for Reconstructive Care

RealSelf Launches Fellowship to Support Medical Volunteers and Raise Awareness of Need for Reconstructive Care

August 18, 2016

FDA approves Libtayo® (cemiplimab-rwlc) as first and only treatment for advanced cutaneous squamous cell carcinoma

FDA approves Libtayo® (cemiplimab-rwlc) as first and only treatment for advanced cutaneous squamous cell carcinoma

October 8, 2018

Alluzience®, the first ready-to-use BoNT-A neuromodulator, receives positive decision for use in Europe

Alluzience®, the first ready-to-use BoNT-A neuromodulator, receives positive decision for use in Europe

July 7, 2021

Search

Login Status

Forgot?  Register

March/April 2026 Issue

Advertisement

Upcoming Events

No events are found.

All events

Categories

  • Injectables
  • Dermatology
  • Anti-ageing
  • Body Contouring
  • Invasive treatments
  • Case Study
  • Practice Management
  • Sponsored
  • Industry Insider
  • Company Profile
  • PRIME People
  • Meeting reviews
  • Commentary

Designed by Elegant Themes | Powered by WordPress

  • Contact Us
  • Editorial Board
  • Terms & Conditions
  • Privacy Policy